(MedPage Today) — Recent developments in the treatment of chronic lymphocytic leukemia (CLL) have included a fixed-duration oral combination regimen for untreated patients and promising results with a Bruton’s tyrosine kinase (BTK) inhibitor in…
Source link : https://www.medpagetoday.com/recent-developments/dlbcl-cll/117683
Author :
Publish date : 2025-09-29 12:45:00
Copyright for syndicated content belongs to the linked Source.
